An innovative nanoparticle vaccine candidate for the pandemic coronavirus produces virus-neutralizing antibodies in mice at levels 10 times greater than is seen in people who have recovered from COVID-19 infections. Designed by scientists at the University of Washington School of Medicine in Seattle, the vaccine candidate has been transferred to two companies for clinical
Watching
Latest
-
China tightens export controls on rare-earth metals: Why this matters | Business and Economy News | Al Jazeera
-
Who Will Protect Us From the Protectors? – Consortium News
-
'Alien' DNA lurks inside human genome, scientist claims
-
“Invasion From Within”: Trump’s Plan to Use the Military in U.S. Cities - The New American